Brandinium

Trademark search for:

SOMMER PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-09-22 — Application filed
  • 2010-09-25 — Application filed
  • 2010-09-26 — Application filed
  • 2010-12-29 — Final disposition recorded
  • 2010-12-29 — Assigned to examiner
  • 2010-12-29 — Final disposition recorded
  • 2010-12-29 — Final disposition recorded
  • 2011-01-03 — Examiner's amendment entered
  • 2011-01-03 — Examiners amendment -written
  • 2011-01-03 — Examiners amendment e-mailed
  • 2011-01-03 — Notification of examiners amendment e-mailed
  • 2011-01-03 — Approved for pub - principal register
  • 2011-02-01 — Assigned to lie
  • 2011-02-02 — Law office publication review completed
  • 2011-03-08 — Published for opposition
  • 2011-03-08 — Official gazette publication confirmation e-mailed
  • 2011-05-03 — Noa e-mailed - sou required from applicant
  • 2011-11-02 — Sou teas extension received
  • 2011-11-02 — Sou extension 1 filed
  • 2011-11-04 — Sou extension 1 granted
  • 2011-11-04 — Case assigned to intent to use paralegal
  • 2011-11-05 — Notice of approval of extension request e-mailed
  • 2012-05-01 — Sou teas extension received
  • 2012-05-01 — Sou extension 2 filed
  • 2012-05-01 — Sou extension 2 granted
  • 2012-05-03 — Notice of approval of extension request e-mailed
  • 2012-11-03 — Sou extension 3 filed
  • 2012-11-05 — Sou teas extension received
  • 2012-11-07 — Sou extension 3 granted
  • 2012-11-08 — Notice of approval of extension request e-mailed
  • 2013-05-02 — Sou teas extension received
  • 2013-05-02 — Sou extension 4 filed
  • 2013-05-02 — Sou extension 4 granted
  • 2013-05-04 — Notice of approval of extension request e-mailed
  • 2013-11-04 — Sou teas extension received
  • 2013-11-04 — Sou extension 5 filed
  • 2013-11-06 — Sou extension 5 granted
  • 2013-11-07 — Notice of approval of extension request e-mailed
  • 2014-05-02 — Teas statement of use received
  • 2014-05-02 — Use amendment filed
  • 2014-05-14 — Statement of use processing complete
  • 2014-06-08 — Allowed principal register - sou accepted
  • 2014-06-10 — Notice of acceptance of statement of use e-mailed
  • 2014-06-30 — Assigned to examiner
  • 2014-07-15 — Registered-principal register
  • 2019-07-15 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2020-07-15 — Teas section 8 & 15 received
  • 2020-09-03 — Notice of acceptance of sec. 8 & 15 - e-mailed
  • 2020-09-03 — Case assigned to post registration paralegal
  • 2020-09-03 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  • 2023-07-15 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  • 2025-02-04 — Cancelled sec. 8 (10-yr)/expired section 9
  • 2025-02-04 — Final status recorded

Owner Information

Sommer Pharmaceuticals-I, LLC
Duncan , SC
Sommer Pharmaceuticals-I, LLC
Duncan , SC
Sommer Pharmaceuticals-I, LLC
Duncan , SC

Correspondent

Scott E. Taylor, Esq. ARNALL GOLDEN GREGORY LLP
171 17th Street NW, Suite 2100
ATLANTA, GA 30363-1031
UNITED STATES

Filing Details

Filing Date:
2010-09-22
Status Date:
2025-02-04
Category:
Pharmaceuticals
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.